Wachtell, Lipton, Rosen & Katz advised Entegris, while Lowenstein Sandler advised Infineum on the deal. Infineum and Entegris, Inc. (NASDAQ: ENTG) have entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Simpson Thacher advised CBRE Group on the deal, while Lowenstein Sandler represented VTS. View the Space, Inc. (VTS), a leading commercial real estate technology platform that...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented LTS Lohmann Therapy Systems, Corp. in the transaction. LTS Lohmann Therapy Systems, Corp. (“LTS”) executed its acquisition of Tapemark Inc. (“Tapemark”) located in...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented NexPhase Capital in the transaction. NexPhase Capital, LP (“NexPhase”), an operationally-focused private equity firm, executed its investment into Aztec Software (“Aztec”), an educational...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Traub Capital Partners in the transaction. Traub Capital Partners announced its majority investment in HITS Shows, the largest producer of hunter/jumper horse shows in...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Signature Brands and its owner Traub Capital Partners in the transaction. Signature Brands, the leading North American manufacturer of dessert decorating products, announced...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt and Lowenstein advised VTS on the acquisition of Lane Technologies, assisted by Fasken Martineau DuMoulin LLP. On October 19, 2021, VTS announced...
You must be a Standard 1 Year member to access this content.
Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Progress on the deal, while Lowenstein represented Mill Point Capital. Progress, the leading provider of products to develop, deploy...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Mill Point Capital in the transaction. Mill Point Capital LLC (Mill Point), a middle-market private equity firm focused on control-oriented investments in the business...
You must be a Standard 1 Year member to access this content.
Lowenstein represented NexPhase Capital in the transaction. NexPhase Capital, LP (NexPhase), an operationally focused private equity firm, completed its investment in Selerix Systems, Inc. (Selerix), a...
You must be a Standard 1 Year member to access this content.
